Literature DB >> 5658680

Late clinical and laboratory manifestations of thorotrast administration in cerebral arteriography. A follow-up study of thirty patients.

M L Janower, V W Sidel, W H Baker, D E Fitzpatrick, F I Guarino, M J Flynn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5658680     DOI： 10.1056/NEJM196807252790404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Cholagiocarcinoma in a patient previously given thorotrast.

Authors:  P K Johnson; R R Babb
Journal:  Am J Dig Dis       Date:  1975-04

2.  [Chromosome anomalies due to thorium deposits in humans].

Authors:  P Citoler; A Gropp; H H Hennekeuser; H Niemczyk
Journal:  Naturwissenschaften       Date:  1969-01

3.  [Clinical, histological and cytogenetic findings in patients with thorotrast lesions].

Authors:  H H Hennekeuser; P Citoler; H Niemczyk; A Gropp
Journal:  Klin Wochenschr       Date:  1970-08-01

4.  Cervical Thorotrast granuloma: an iatrogenic cause of dysphagia.

Authors:  M Burrell
Journal:  Gastrointest Radiol       Date:  1977-12-20

5.  Spurious dual-energy X-ray absorptiometry images in a patient exposed to the contrast agent Thorotrast.

Authors:  D Stern; R Zamenhof; B Dawson-Hughes
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

6.  Haemangioendothelioma (Kupffer cell angiosarcoma), myelofibrosis, splenic atrophy, and myeloma paraproteinaemia after parenteral thorotrast administration.

Authors:  R C Jennings; S E Priestley
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.